FDA Notices of Judgment Collection, 1908-1966
4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.
Drugs and Devices, 1940-1963 Evidence Numbers:
F. D. C. No. 34841. Sample Nos. 46279-L to 46283-L, incl. , 46285-L.
June 1954 Seizure Dates:
July 18, 21, 26, 28, and 29, 1952
dextro-amphetamine sulfate tablets and secobarbital sodium capsules
Clyde King, trading as the Clyde King Drug Co., Birmingham, Ala., and Benjamin H. Darnell, a pharmacist for the company. Court Jurisdiction:
Northern District of Alabama Seizure Location:
The National Library of Medicine believes this item to be in the public domain